We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

104 hedge funds and large institutions have $317M invested in Aura Biosciences in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

37% more capital invested

Capital invested by funds: $232M → $317M (+$85.3M)

21.35% more ownership

Funds ownership: 79.35% → 100.69% (+21%)

11% more funds holding

Funds holding: 94 → 104 (+10)

10% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 29

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
104
Holders Change
+10
Holders Change %
+10.64%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
32
Reduced
29
Closed
15
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
+$29.8M
2
SCM
Suvretta Capital Management
New York
+$9.6M
3
LFCM
Long Focus Capital Management
Puerto Rico
+$7.6M
4
SB
Samsara BioCapital
California
+$5.85M
5
NCM
Nantahala Capital Management
Connecticut
+$4.97M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.56M
2
UOC
UBS O'Connor
Illinois
-$885K
3
Citadel Advisors
Citadel Advisors
Florida
-$884K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$559K
5
RCM
Regency Capital Management
Hawaii
-$489K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$941K +$297K +50,841 +51%
PIM
27
Platinum Investment Management
Australia
$848K -$158K -26,956 -17%
Renaissance Technologies
28
Renaissance Technologies
New York
$823K +$165K +28,248 +27%
Millennium Management
29
Millennium Management
New York
$777K +$726K +124,059 New
Charles Schwab
30
Charles Schwab
California
$749K -$110K -18,815 -14%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$584K -$80.5K -13,770 -13%
RCAP
32
Resolute Capital Asset Partners
Colorado
$570K +$532K +91,006 New
Ameriprise
33
Ameriprise
Minnesota
$529K +$117K +20,065 +31%
N
34
Nuveen
North Carolina
$453K -$137K -23,372 -24%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$432K – – –
Barclays
36
Barclays
United Kingdom
$429K +$106K +18,156 +36%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$409K +$8.01K +1,369 +2%
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$379K -$10.6K -1,818 -3%
TGAM
39
TBH Global Asset Management
Tennessee
$378K – – –
SPS
40
Susquehanna Portfolio Strategies
Pennsylvania
$356K +$332K +56,798 New
HF
41
HRT Financial
New York
$353K +$331K +56,529 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$329K -$28K -4,790 -8%
American Century Companies
43
American Century Companies
Missouri
$295K -$26.9K -4,608 -9%
ECM
44
ExodusPoint Capital Management
New York
$273K +$255K +43,550 New
AllianceBernstein
45
AllianceBernstein
Tennessee
$261K +$104K +17,840 +75%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$242K +$197K +33,689 +682%
HCA
47
Harbor Capital Advisors
Illinois
$205K +$40.9K +6,998 +27%
Commonwealth Equity Services
48
Commonwealth Equity Services
Massachusetts
$194K +$3.97K +679 +2%
AI
49
Atria Investments
North Carolina
$190K +$177K +30,309 New
GFA
50
Gallagher Fiduciary Advisors
Illinois
$189K +$177K +30,239 New
1
2
3 4 5

AURA Hedge Fund Activity: Q2 2025 in Review

104 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2025, worth a combined $317M — up 37% from $232M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new AURA positions and 15 closed out — a net gain of 11 holders — while 32 added to existing stakes and 29 trimmed.

The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $29.8M. The largest seller was BlackRock, cutting an estimated $2.56M.

  • 104 institutional investors held Aura Biosciences (AURA) as of Q2 2025, up from 94 in Q1 2025.
  • Funds reported $317M of Aura Biosciences stock for Q2 2025, up 37% quarter-over-quarter.
  • 26 funds opened new Aura Biosciences positions in Q2 2025 and 15 closed out, a net change of +11 holders.
  • The largest Aura Biosciences buyer in Q2 2025 was Frazier Life Sciences Management, an estimated $29.8M added.
  • The largest Aura Biosciences seller in Q2 2025 was BlackRock, an estimated $2.56M sold.

Based on aggregated 13F filings for Q2 2025.